---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-011909"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T06:03:17.829167+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Lyn Baranowski will not stand for re-election at 2023 annual meeting

## Summary
- Lyn Baranowski notified Rani Therapeutics she will not stand for re-election at the 2023 annual meeting.
- She will cease to be a board member and member of Compensation and Nominating/Governance committees effective at the meeting.
- Decision not due to any disagreement with the company on operations, policies, or practices.

## SEC filing metadata
- accession: 0000950170-23-011909
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/0000950170-23-011909-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/rani-20230330.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-011909
- JSON: https://secwatch.observer/filing/0000950170-23-011909.json
- Plain text: https://secwatch.observer/filing/0000950170-23-011909.txt

## Key facts
- Executive change
  Lyn Baranowski departed as Director at Rani Therapeutics Holdings, Inc..
  - Action: does not intend to stand for re-election
  - Role: Director
  source text: On March 30, 2023, Ms. Lyn Baranowski notified Rani Therapeutics Holdings, Inc. (the “Company”) that she does not intend to stand for re-election at the 2023 annual meeting of stockholders of the Company (“Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/0000950170-23-011909-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.